Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 2/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25569493 | 0.87 | TSHR (0.44) | TSHRALDH1A1LMNATYRKIF11 | |
| SCHEMBL20033214 | 0.85 | TSHR (0.38) | TSHRALDH1A1LMNATYRKIF11 | |
| SCHEMBL24926243 | 0.84 | TSHR (0.34) | TSHRALDH1A1LMNALOXL2RAB9A | |
| SCHEMBL22002106 | 0.84 | ALOX5AP (0.39) | TSHRALDH1A1KIF11LOXL2DGAT1 | |
| SCHEMBL14327692 | 0.84 | ALOX5AP (0.39) | TSHRALDH1A1KIF11LOXL2DGAT1 | |
| SCHEMBL20712779 | 0.84 | TSHR (0.36) | TSHRALDH1A1LMNATYRKIF11 | |
| SCHEMBL77362 | 0.84 | TRPV4 (0.54) | TSHRALDH1A1LMNATYRKIF11 | |
| SCHEMBL21728746 | 0.84 | TSHR (0.36) | TSHRALDH1A1LMNATYRKIF11 | |
| SCHEMBL20712281 | 0.84 | ALDH1A1 (0.38) | TSHRALDH1A1LMNATYRKIF11 | |
| SCHEMBL803453 | 0.84 | KMT2A (0.44) | TSHRALDH1A1LMNARAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112094300-A | Dicyano tetra-tert-butyl pyridine ruthenium metal organic compound, preparation method and application thereof | 荆楚理工学院 | 2020-12-18 | — | — | CN | claimed |
| US-8697820-B2 | Process for preparing high-reactivity isobutene homo- or copolymers | BASF SE (DE) | 2014-04-15 | — | — | US | claimed |
| US-8257493-B2 | Photonic crystal, conjugated polymers suitable for photonic crystal, and a method for synthesizing conjugated polymers | THE UNIVERSITY OF AKRON (US) | 2012-09-04 | — | — | US | claimed |
| US-20240239776-A1 | AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2024-07-18 | — | — | US | disclosed |
| US-20240239776-A1 | AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2024-07-18 | — | — | US | disclosed |
| US-20240238425-A1 | HSD17B13 Inhibitors and/or Degraders | PFIZER INC. (US) | 2024-07-18 | — | — | US | disclosed |
| US-20240228490-A1 | HETEROCYCLIC DERIVATIVE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240228490-A1 | HETEROCYCLIC DERIVATIVE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240226107-A1 | UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR | HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240226107-A1 | UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR | HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-12035618-B2 | Electroluminescent devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20020161153-A1 | Polarizable photoactive and electroactive polymers and light emitting devices | BAO ZHENAN (US) | 2002-10-31 | — | — | US | disclosed |
| US-6383665-B1 | POLYPHENYLENEVINYLENES, POLYTHIOPHENES, POLYFURANS, POLYPYRIDINES AND POLYACETYLENES; THERMOTROPIC AND LYOTROPIC LIQUID CRYSTAL POLYMERS | LUCENT TECHNOLOGIES INC. | 2002-05-07 | — | — | US | disclosed |
| CN-1042026-C | 25Carboxylic derivative of vitamin D series, middle products in production of same and pharmaceutical containing same and use of same in treatment | SCHERING AG (DE) | 1999-02-10 | — | — | CN | disclosed |
| EP-0663902-B1 | 25-CARBOXYLIC ACID DERIVATIVES IN THE VITAMIN D SERIES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN THE MANUFACTURE OF MEDICINES | SCHERING AG (DE) | 1998-03-11 | — | — | EP | disclosed |
| US-5583125-A | SKIN DISORDERS, ANTITUMOR AGENTS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-12-10 | — | — | US | disclosed |
| WO-1995031489-A1 | CARBOCATIONIC CATALYSTS AND PROCESS FOR USING SAID CATALYSTS | EXXON CHEMICAL PATENTS INC. (US) | 1995-11-23 | — | — | WO | disclosed |
| EP-0663902-A1 | 25-CARBOXYLIC ACID DERIVATIVES IN THE VITAMIN D SERIES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN THE MANUFACTURE OF MEDICINES | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-07-26 | — | — | EP | disclosed |
| CN-1094034-A | 25 carboxylic acid derivative of vitamin D series, its method for making and intermediate product, contain the medicine of this derivative and medicinal | SCHERING AG (DE) | 1994-10-26 | — | — | CN | disclosed |
| WO-1994007853-A1 | 25-CARBOXYLIC ACID DERIVATIVES IN THE VITAMIN D SERIES, METHOD OF PRODUCING THEM, INTERMEDIATE PRODUCTS FOR THIS METHOD, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN THE MANUFACTURE OF MEDICINES | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238425-A1 | HSD17B13 Inhibitors and/or Degraders | HSD17B13, HSD17B3, HSD17B1 | TSHR 2988/4885ALDH1A1 98/4885LMNA 1598/4885 |
| US-20240228490-A1 | HETEROCYCLIC DERIVATIVE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | WEE1, CYP51A1, WEE2 | TSHR 4671/4885ALDH1A1 252/4885LMNA 1581/4885 |
| US-12035618-B2 | Electroluminescent devices | ELAVL1, ELAVL3, JUND | TSHR 4120/4885ALDH1A1 1948/4885LMNA 2563/4885 |
| US-20240226107-A1 | UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR | USP1, USP2, USP3 | TSHR 4093/4885ALDH1A1 582/4885LMNA 3658/4885 |
| US-20240239776-A1 | AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS | MGLL, LPL, LPAR1 | TSHR 909/4885ALDH1A1 245/4885LMNA 1948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.